Sano M - Search Results

1

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan.

Tokudome N, Ito Y, Hatake K, Toi M, Sano M, Iwata H, Sato Y, Saeki T, Aogi K, Takashima S. Tokudome N, et al. Among authors: sano m. Anticancer Drugs. 2008 Aug;19(7):753-9. doi: 10.1097/CAD.0b013e328302eb15. Anticancer Drugs. 2008. PMID: 18594220 Clinical Trial.

2

Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes.

Toi M, Saeki T, Aogi K, Sano M, Hatake K, Asaga T, Tokuda Y, Mitsuyama S, Kimura M, Kobayashi T, Tamura M, Tabei T, Shin E, Nishimura R, Ohno S, Takashima S. Toi M, et al. Among authors: sano m. Jpn J Clin Oncol. 2005 Jun;35(6):310-5. doi: 10.1093/jjco/hyi090. Epub 2005 Jun 1. Jpn J Clin Oncol. 2005. PMID: 15930037 Clinical Trial.

3

[A phase-I clinical study of a combination therapy of vinorelbine and capecitabine in patients with advanced/recurrent breast cancer].

Sano M, Tokuda Y, Noguchi S, Aogi K, Saeki T, Tabei T, Hatake K, Fujii H. Sano M, et al. Gan To Kagaku Ryoho. 2006 Aug;33(8):1091-7. Gan To Kagaku Ryoho. 2006. PMID: 16912527 Clinical Trial. Japanese.

4

[Late phase II study of exemestane in postmenopausal patients with breast cancer resistant to anti-estrogenic agents].

Watanabe T, Sano M, Toi M, Saeki T, Kanda K, Miura S, Inaji H, Sono H, Saeki H, Nishimura R, Fujita Y. Watanabe T, et al. Among authors: sano m. Gan To Kagaku Ryoho. 2002 Jul;29(7):1211-21. Gan To Kagaku Ryoho. 2002. PMID: 12146002 Clinical Trial. Japanese.

5

[A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].

Saeki T, Takashima S, Sano M, Horikoshi N, Miura S, Shimizu S, Morimoto K, Kimura M, Taguchi T. Saeki T, et al. Among authors: sano m. Gan To Kagaku Ryoho. 2004 Apr;31(4):539-47. Gan To Kagaku Ryoho. 2004. PMID: 15114697 Clinical Trial. Japanese.

6

A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working Group.

Saek T, Takashima S, Sano M, Horikoshi N, Miura S, Shimizu S, Morimoto K, Kimura M, Aoyama H, Ota J, Noguchi S, Taguchi T. Saek T, et al. Among authors: sano m. Breast Cancer. 2004;11(2):194-202. doi: 10.1007/BF02968301. Breast Cancer. 2004. PMID: 15550867 Clinical Trial.

7

Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208.

Tokuda Y, Tajima T, Narabayashi M, Takeyama K, Watanabe T, Fukutomi T, Chou T, Sano M, Igarashi T, Sasaki Y, Ogura M, Miura S, Okamoto S, Ogita M, Kasai M, Kobayashi T, Fukuda H, Takashima S, Tobinai K; Autologous Bone Marrow Transplantation Study Group; Breast Cancer Study Group of the Japan Clinical Oncology Group (JCOG). Tokuda Y, et al. Among authors: sano m. Cancer Sci. 2008 Jan;99(1):145-51. doi: 10.1111/j.1349-7006.2007.00639.x. Epub 2007 Oct 25. Cancer Sci. 2008. PMID: 17970786 Free PMC article. Clinical Trial.

8

Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.

Watanabe T, Sano M, Takashima S, Kitaya T, Tokuda Y, Yoshimoto M, Kohno N, Nakagami K, Iwata H, Shimozuma K, Sonoo H, Tsuda H, Sakamoto G, Ohashi Y. Watanabe T, et al. Among authors: sano m. J Clin Oncol. 2009 Mar 20;27(9):1368-74. doi: 10.1200/JCO.2008.18.3939. Epub 2009 Feb 9. J Clin Oncol. 2009. PMID: 19204202 Clinical Trial.

9

1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery: a randomized controlled trial.

Tominaga T, Kimura M, Asaga T, Yoshida M, Awane H, Koyama H, Takatsuka Y, Mitsuyama S, Ikeda T, Ogita M, Aoyama H, Sano M, Abe R, Nishi T, Wada T, Danno M, Toi M, Takashima S. Tominaga T, et al. Among authors: sano m. Oncol Rep. 2004 Oct;12(4):797-803. Oncol Rep. 2004. PMID: 15375502 Clinical Trial.

10

[CGS 20267 (Letrozole), a new aromatase inhibitor: early phase II study for postmenopausal women with advanced breast cancer].

Nomura Y, Tominaga T, Enomoto K, Aoyama H, Nakamura Y, Abe R, Sano M, Nomizu T, Tohge T, Takashima S, Ohashi Y. Nomura Y, et al. Among authors: sano m. Gan To Kagaku Ryoho. 2002 Apr;29(4):551-62. Gan To Kagaku Ryoho. 2002. PMID: 11977539 Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,632 results

Search Page

Filters